Neuroimaging findings in the at-risk mental state: A review of recent literature

Canadian Journal of Psychiatry

Volumn 58, Issue 1, 2013, Pages 13-18

  Wood, Stephen J ^a,b   Reniers, Renate L E P ^a   Heinze, Kareen ^a  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^b UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

At risk mental state; Neuroimaging; Prodrome; Schizophrenia

Indexed keywords

N ACETYLASPARTIC ACID;

DIFFUSION TENSOR IMAGING; DOPAMINE METABOLISM; FUNCTIONAL MAGNETIC RESONANCE IMAGING; HUMAN; MENTAL HEALTH; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; PSYCHOSIS; REVIEW; RISK ASSESSMENT; SCHIZOPHRENIA; STRESS; SUPERIOR TEMPORAL GYRUS; TASK PERFORMANCE;

EID: 84873053643     PISSN: 07067437     EISSN: 14970015     Source Type: Journal    
DOI: 10.1177/070674371305800104     Document Type: Review

References (67)

1. Yung AR, McGorry PD. The prodromal phase of first-episode psychosis: past and current conceptualizations. Schizophr Bull. 1996;22(2):353-370.
2. Yung AR, Yuen HP, McGorry PD, et al. Mapping the onset of psychosis-the Comprehensive Assessment of At Risk Mental States (CAARMS). Aust N Z J Psychiatry. 2005;39:964-971.
3. Miller TJ, McGlashan TH, Rosen JL, et al. Prodromal assessment with the structured interview for prodromal syndromes and the scale of prodromal symptoms: predictive validity, interrater reliability, and training to reliability. Schizophr Bull. 2003;29(4):703-715.
4. Yung AR. Identification and treatment of the prodromal phase of psychotic disorders: perspectives from the PACE Clinic. Early Interv Psychiatry. 2007;1:224-235.
5. Olsen KA, Rosenbaum B. Prospective investigations of the prodromal state of schizophrenia: review of studies. Acta Psychiatr Scand. 2006;113:247-272.
6. Copolov D, Velakoulis D, McGorry PD, et al. Neurobiological findings in prodromal and early phase schizophrenia. Brain Res Rev. 2000;31:157-165.
7. Wood SJ, Pantelis C, Velakoulis D, et al. Progressive changes in the development toward schizophrenia: studies in subjects at increased symptomatic risk. Schizophr Bull. 2008;34(2):322-329.
8. Karlsgodt KH, Sun D, Jimenez AM, et al. Developmental disruptions in neural connectivity in the pathophysiology of schizophrenia. Dev Psychopathol. 2008;20:1297-1327.
9. Brugger S, Davis JM, Leucht S, et al. Proton magnetic resonance spectroscopy and illness stage in schizophrenia-a systematic review and meta-analysis. Biol Psychiatry. 2011;69:495-503.
10. Fusar-Poli P. Voxel-wise meta-analysis of fMRI studies in patients at clinical high risk for psychosis. J Psychiatry Neurosci. 2012;37:106-112.
11. Fusar-Poli P, Borgwardt S, Crescini A, et al. Neuroanatomy of vulnerability to psychosis: a voxel-based meta-analysis. Neurosci Biobehav Rev. 2011;35:1175-1185.
12. Jung WH, Jang JH, Byun MS, et al. Structural brain alterations in individuals at ultra-high risk for psychosis: a review of magnetic resonance imaging studies and future directions. J Korean Med Sci. 2010;25:1700-1709.
13. Mechelli A, Riecher-Rossler A, Meisenzahl EM, et al. Neuroanatomical abnormalities that predate the onset of psychosis: a multicenter study. Arch Gen Psychiatry. 2011;68(5):489-495.
14. Fusar-Poli P, Crossley N, Woolley J, et al. Gray matter alterations related to P300 abnormalities in subjects at high risk for psychosis: longitudinal MRI-EEG study. NeuroImage. 2011;55(1):320-328.
15. Witthaus HMD, Mendes UMD, Brune MMDP, et al. Hippocampal subdivision and amygdalar volumes in patients in an at-risk mental state for schizophrenia. J Psychiatry Neurosci. 2010;35(1):33-40.
16. Wood SJ, Kennedy D, Phillips LJ, et al. Hippocampal pathology in individuals at ultra-high risk for psychosis: a multi-modal magnetic resonance study. NeuroImage. 2010;52(1):62-68.
17. Buehlmann E, Berger GE, Aston J, et al. Hippocampus abnormalities in at risk mental states for psychosis? A crosssectional high resolution region of interest magnetic resonance imaging study. J Psychiatr Res. 2010;44(7):447-453.
18. Koutsouleris N, Gaser C, Bottlender R, et al. Use of neuroanatomical pattern regression to predict the structural brain dynamics of vulnerability and transition to psychosis. Schizophr Res. 2010;123(2-3):175-187.
19. Berger GE, Wood SJ, Velakoulis D, et al. Ventricle volumes in emerging psychosis. A cross-sectional and longitudinal MRI study. Eur Psychiatry. 2007;22:S30-S31.
20. Dazzan P, Soulsby B, Mechelli A, et al. Volumetric abnormalities predating the onset of schizophrenia and affective psychoses: an MRI study in subjects at ultrahigh risk of psychosis. Schizophr Bull. 2012;38(5):1083-1091.
21. Velakoulis D, Wood SJ, Wong MTH, et al. Hippocampal and amygdala volumes differ according to psychosis stage and diagnosis: an MRI study of chronic schizophrenia, first-episode psychosis and ultra-high risk subjects. Arch Gen Psychiatry. 2006;63:139-149.
22. Smieskova R, Fusar-Poli P, Aston J, et al. Insular volume abnormalities associated with different transition probabilities to psychosis. Psychol Med. 2012;42(8):1613-1625.
23. Takahashi T, Wood SJ, Yung AR, et al. Insular cortex gray matter changes in individuals at ultra-high-risk of developing psychosis. Schizophr Res. 2009;111:94-102.
24. Smieskova R, Allen P, Simon A, et al. Different duration of at-risk mental state associated with neurofunctional abnormalities. A multimodal imaging study. Hum Brain Mapp. 2012;33(10):2281-2294.
25. Jung WH, Kim JS, Jang JH, et al. Cortical thickness reduction in individuals at ultra-high-risk for psychosis. Schizophr Bull. 2011;37(4):839-849.
26. Fusar-Poli P, Broome MR, Woolley JB, et al. Altered brain function directly related to structural abnormalities in people at ultra high risk of psychosis: longitudinal VBM-fMRI study. J Psychiatr Res. 2011;45(2):190-198.
27. Takahashi T, Wood SJ, Yung AR, et al. Superior temporal gyrus volume in antipsychotic-naive people at risk of psychosis. Br J Psychiatry. 2010;196(3):206-211.
28. Hannan KL, Wood SJ, Yung AR, et al. Caudate nucleus volume in individuals at ultra-high risk of psychosis: a crosssectional magnetic resonance imaging study. Psychiatry Res. 2010;182(3):223-230.
29. Garner B, Pariante CM, Wood SJ, et al. Pituitary volume predicts future transition to psychosis in individuals at ultra-high-risk of developing psychosis. Biol Psychiatry. 2005;58:417-423.
30. Büschlen J, Berger GE, Borgwardt SJ, et al. Pituitary volume increase during emerging psychosis. Schizophr Res. 2011;125(1):41-48.
31. Dorph-Petersen K-A, Pierri JN, Perel JM, et al. The influence of chronic exposure to antipsychotic medications on brain size before and after tissue fixation: a comparison of haloperidol and olanzapine in macaque monkeys. Neuropsychopharmacology. 2005;30:1649-1661.
32. Konopaske GT, Dorph-Petersen K-A, Pierri JN, et al. Effect of chronic exposure to antipsychotic medication on cell numbers in the parietal cortex of macaque monkeys. Neuropsychopharmacology. 2007;32:1216-1223.
33. Fusar-Poli P, Radua J, McGuire P, et al. Neuroanatomical maps of psychosis onset: voxel-wise meta-analysis of antipsychotic-naive VBM studies. Schizophr Bull. 2012;38(6):1297-1307.
34. Machielsen M, van der Sluis S, de Haan L. Cannabis use in patients with a first psychotic episode and subjects at ultra high risk of psychosis: impact on psychotic- and pre-psychotic symptoms. Aust N Z J Psychiatry. 2010;44:721-728.
35. Yücel M, Solowij N, Respondek C, et al. Regional brain abnormalities associated with long-term heavy cannabis use. Arch Gen Psychiatry. 2008;65:694-701.
36. Rais M, Cahn W, van Haren NEM, et al. Excessive brain volume loss over time in cannabis-using first-episode schizophrenia patients. Am J Psychiatry. 2008;165:490-496.
37. Allen P, Seal ML, Valli I, et al. Altered prefrontal and hippocampal function during verbal encoding and recognition in people with prodromal symptoms of psychosis. Schizophr Bull. 2011;37(4):746-756.
38. Broome M, Fusar-Poli P, Matthiasson P, et al. Neural correlates of visuospatial working memory in the 'at-risk mental state.' Psychol Med. 2010;40(12):1987-1999
39. Fusar-Poli P, Howes OD, Allen P, et al. Abnormal frontostriatal interactions in people with prodromal signs of psychosis: a multimodal imaging study. Arch Gen Psychiatry. 2010;67(7):683-691.
40. Fusar-Poli P, Broome MR, Matthiasson P, et al. Prefrontal function at presentation directly related to clinical outcome in people at ultrahigh risk of psychosis. Schizophr Bull. 2011;37(1):189-198.
41. Fusar-Poli P, Howes OD, Allen P, et al. Abnormal prefrontal activation directly related to pre-synaptic striatal dopamine dysfunction in people at clinical high risk for psychosis. Mol Psychiatry. 2011;16(1):67-75.
42. Pauly K, Seiferth NY, Kellermann T, et al. The interaction of working memory and emotion in persons clinically at risk for psychosis: an fMRI pilot study. Schizophr Res. 2010;120(1-3):167-176.
43. Sabb FW, van Erp TGM, Hardt ME, et al. Language network dysfunction as a predictor of outcome in youth at clinical high risk for psychosis. Schizophr Res. 2010;116(2-3):173-183.
44. Brüne M, Ozgürdal S, Ansorge N, et al. An fMRI study of "theory of mind" in at-risk states of psychosis: comparison with manifest schizophrenia and healthy controls. NeuroImage. 2011;55:329-337.
45. Allen P, Stephan KE, Mechelli A, et al. Cingulate activity and fronto-temporal connectivity in people with prodromal signs of psychosis. NeuroImage. 2010;49(1):947-955.
46. Fusar-Poli P, Broome MR, Matthiasson P, et al. Spatial working memory in individuals at high risk for psychosis: longitudinal fMRI study. Schizophr Res. 2010;123(1):45-52.
47. Lord L-D, Allen P, Expert P, et al. Characterization of the anterior cingulate's role in the at-risk mental state using graph theory. NeuroImage. 2011;56(3):1531-1539.
48. Menon V. Large-scale brain networks and psychopathology: a unifying triple network model. Trends Cogn Sci. 2011;15:483-506.
49. Shim G, Oh JS, Jung WH, et al. Altered resting-state connectivity in subjects at ultra-high risk for psychosis: an fMRI study. Behav Brain Funct. 2010;6:58.
50. Uhl I, Mavrogiorgou P, Norra C, et al. 1 H-MR spectroscopy in ultra-high risk and first episode stages of schizophrenia. J Psychiatr Res. 2011;45(9):1135-1139.
51. de la Fuente-Sandoval C, Leon-Ortiz P, Favila R, et al. Higher levels of glutamate in the associative-striatum of subjects with prodromal symptoms of schizophrenia and patients with first-episode psychosis. Neuropsychopharmacology. 2011;36(9):1781-1791.
52. Stone JM, Bramon E, Pauls A, et al. Thalamic neurochemical abnormalities in individuals with prodromal symptoms of schizophrenia-relationship to auditory event-related potentials. Psychiatry Res. 2010;183(2):174-176.
53. Valli I, Stone J, Mechelli A, et al. Altered medial temporal activation related to local glutamate levels in subjects with prodromal signs of psychosis. Biol Psychiatry. 2011;69(1):97-99.
54. Stone JM, Howes OD, Egerton A, et al. Altered relationship between hippocampal glutamate levels and striatal dopamine function in subjects at ultra high risk of psychosis. Biol Psychiatry. 2010;68(7):599-602.
55. Allen P, Chaddock CA, Howes OD, et al. Abnormal relationship between medial temporal lobe and subcortical dopamine function in people with an ultra high risk for psychosis. Schizophr Bull. 2012;38(5):1040-1049.
56. Bloemen OJN, de Koning MB, Schmitz N, et al. White-matter markers for psychosis in a prospective ultra-high-risk cohort. Psychol Med. 2010;40(8):1297-1304.
57. Peters BD, Dingemans PM, Dekker N, et al. White matter connectivity and psychosis in ultra-high-risk subjects: a diffusion tensor fiber tracking study. Psychiatry Res. 2010;181(1):44-50.
58. Bartlett PA, Symms MR, Free SL, et al. T2 relaxometry of the hippocampus at 3T. Am J Neuroradiol. 2007;28:1095-1098.
59. Whittall KP, MacKay AL, Graeb DA, et al. In vivo measurement of T2 distributions and water contents in normal human brain. Magn Reson Med. 1997;37(1):34-43.
60. Howes O, Montgomery AJ, Asselin M-C, et al. Elevated striatal dopamine function linked to prodromal signs of schizophrenia. Arch Gen Psychiatry. 2009;66(1):13-20.
61. Howes OD, Bose SK, Turkheimer F, et al. Dopamine synthesis capacity before onset of psychosis: a prospective [18F]-DOPA PET imaging study. Am J Psychiatry. 2011;168(12):1311-1317.
62. Howes O, Bose SK, Turkheimer F, et al. Progressive increase in striatal dopamine synthesis capacity as patients develop psychosis: a PET study. Mol Psychiatry. 2011;16:885-888.
63. McGlashan TH, Zipursky RB, Perkins D, et al. Randomized, doubleblind trial of olanzapine versus placebo in patients prodromally symptomatic for psychosis. Am J Psychiatry. 2006;163:790-799.
64. McGorry PD, Yung AR, Phillips LJ, et al. Randomized controlled trial of interventions designed to reduce the risk of progression to first-episode psychosis in a clinical sample with subthreshold symptoms. Arch Gen Psychiatry. 2002;59:921-928.
65. Fusar-Poli P, Perez J, Broome MR, et al. Neurofunctional correlates of vulnerability to psychosis: a systematic review and meta-analysis. Neurosci Biobehav Rev. 2007;31:465-484.
66. Wood SJ, Pantelis C, Yung AR, et al. Brain changes during the onset of schizophrenia: implications for neurodevelopmental theories. Med J Aust. 2009;190(4 Suppl):S10-S13.
67. Wood SJ, Yung AR, McGorry PD, et al. Neuroimaging and treatment evidence for clinical staging in psychotic disorders: from the at-risk mental state to chronic schizophrenia. Biol Psychiatry. 2011;70:619-625.